Clinical Trials Directory

Trials / Unknown

UnknownNCT01703013

The Significance of Defensin Alpha 4 in the Pathophysiology of the Adrenal Insufficiency in Inflammatory Lung Diseases

Status
Unknown
Phase
Study type
Observational
Enrollment
75 (estimated)
Sponsor
Cantonal Hospital of St. Gallen · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

The pathophysiology of the adrenal insufficiency of patients with critical diseases remains unclear. In a prior exploratory study investigating patients with exacerbation of chronic obstructive pulmonary disease (COPD), the investigators demonstrated a highly significant correlation between the expression level of Defensin-alpha 4 (DEFA4) mRNA in blood and the adrenal function assessed via low-dose ACTH tests. The aim of this prospective study is to demonstrate that DEFA4 measured both at the mRNA level (RT-PCR) and at the protein level (Western blot/Elisa) is a reliable biomarker for the prediction of adrenal insufficiency in inflammatory lung diseases (patients with COPD and pneumonia).

Conditions

Timeline

Start date
2013-01-01
First posted
2012-10-10
Last updated
2012-10-10

Source: ClinicalTrials.gov record NCT01703013. Inclusion in this directory is not an endorsement.